What do you do if you have a CME activity planned, say, for tomorrow on breast cancer prevention and treatment, and a controversial new mammography guideline comes out that contradicts long-standing previous standards of care? ...
While Murray Kopelow, MD, chief executive of the Accreditation Council for Continuing Medical Education, declined to answer specific questions about his announcement in an article recently published in The New York Times that ACCME would “make...
The third time may be the charm for some things, but not for the American Medical Association’s Council on Ethical and Judicial Affairs, whose report on commercial support was yet again sent back to the drawing board after a third request that AMA...
One of the largest medical meetings in the country has selected Las Vegas as the site of its 2012 annual conference, with officials citing the economy as a critical factor in the decision. It will be the first time the Healthcare Information and...
While of course no one's talking on record, my colleague Rachel Eccles managed to dig up some information about the potential impact of the Pfizer-Wyeth merger on its meetings and medical meetings department. ...
Pfizer completed its $67 billion acquisition of one-time-competitor Wyeth Pharmaceuticals on October 15, just one in a string of recent mergers and acquisitions in the pharmaceutical industry. (Think Merck’s November 3 merger with Schering-Plough...
